Latest Strategy News

Sonic Healthcare reported solid FY2025 results with revenue up 7.6% and a steady profit increase, while declaring a 63-cent final dividend. The company’s recent German acquisition and ongoing synergy efforts set the stage for robust earnings growth in FY2026.

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.

Infinity Mining’s re-assay of historic stream sediment samples at its Tanjil Bren Project reveals elevated gold and pathfinder elements, highlighting promising intrusion-related gold system signatures.

Whitehaven Coal has announced an extension of its on-market share buy-back program, committing up to $48 million in purchases through December 2025, reinforcing its shareholder return strategy.

National Storage REIT delivered a solid FY25 with a 6.4% rise in underlying earnings and a robust $303 million acquisition spree, underpinning its growth ambitions amid a strong development pipeline.

NAOS Small Cap Opportunities Company Limited reported a significantly reduced loss for FY25 and declared a final quarterly dividend, while outlining a cautiously optimistic outlook for FY26 driven by core portfolio improvements.

Qube Holdings has reported a landmark FY25 with underlying revenue soaring 27.3% to $4.46 billion and earnings rising across all key metrics, despite industrial action and adverse weather disruptions.

National Storage REIT has announced its final ordinary dividend for FY25 at AUD 0.056 per security, accompanied by a Dividend Reinvestment Plan offering a 2% discount on new units. The payment is scheduled for early September, marking a steady income stream for investors.

Whitehaven Coal reported a robust FY25 with underlying NPAT of $319 million and record production, while maintaining a strong balance sheet and announcing shareholder returns. The company’s FY26 guidance signals continued operational focus amid stabilizing coal markets.

IDT Australia Limited reported a strong 40.6% increase in revenue to $19.86 million for FY25, driven by growth in advanced therapies and contract disbursements. However, the company’s net loss widened to $8.06 million as it transitions from its ‘Rebuild Strategy’ to a new phase focused on sustainable profitability.

NAOS Ex-50 Opportunities Company Limited (ASX, NAC) reported a strong turnaround with a $7.55 million profit after tax for FY25 and a 28.9% portfolio return, declaring a 1.5 cent per share dividend. The company’s focused investments in emerging Australian and New Zealand companies underpin its robust performance and disciplined capital management.

NAOS Emerging Opportunities Company Limited (ASX, NCC) has reported a significant profit turnaround for FY25, alongside a fully franked dividend declaration and strategic portfolio developments.